
Vivani to spin out neurostim business, focus on GLP-1 implant
Vivani Medical (Nasdaq:VANI) today announced steps enabling it to focus solely on its GLP-1-delivering implant technologies. Our sister site, Drug Delivery Business News, reports today that Vivani plans to spin off Cortigent, a division that develops brain …